The U.S. Centers for Disease Control and Prevention warned Monday that cases of Candida auris, or C. auris — a potentially deadly and drug-resistant fungal infection — are on the rise at U.S. health-care facilities.
New CDC data published in the journal Annals of Internal Medicine showed that the number of infections has grown since it was first detected in the U.S. in 2013. The rate has increased rapidly in recent years, however.
There were 756 reported cases in 2020 and 1,471 reported cases in 2021 — a 95% increase. According to preliminary CDC data, from January to December 2022, the U.S. reported 2,377 cases and 5,754 screening cases.
